VoluSense develops mask-free systems for lung function evaluation. Our first product is for hospitalised infants.

VoluSense Pediatrics helps neonatologists and pediatricians when they are evaluating the need, or the efficacy, or in some cases the harm of any clinical intervention intended to benefit preterm or term infants.

VoluSense Pediatrics was cleared for clinical use by EU regulators in 2014 and is initially rolled out to selected pilot hospitals. Clinicians interested in trial use or preorders are invited to contact us.

Follow us: